• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人α/β 水解酶结构域包含 10 (ABHD10)是负责酶去葡糖醛酸化麦考酚酸酰 - 葡糖醛酸在肝脏。

Human α/β hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liver.

机构信息

Department of Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan.

出版信息

J Biol Chem. 2012 Mar 16;287(12):9240-9. doi: 10.1074/jbc.M111.271288. Epub 2012 Jan 31.

DOI:10.1074/jbc.M111.271288
PMID:22294686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3308823/
Abstract

Mycophenolic acid (MPA), the active metabolite of the immunosuppressant mycophenolate mofetil (MMF), is primarily metabolized by glucuronidation to a phenolic glucuronide (MPAG) and an acyl glucuronide (AcMPAG). It is known that AcMPAG, which may be an immunotoxic metabolite, is deglucuronidated in human liver. However, it has been reported that recombinant β-glucuronidase does not catalyze this reaction. AcMPAG deglucuronidation activity was detected in both human liver cytosol (HLC) and microsomes (HLM). In this study, the enzyme responsible for AcMPAG deglucuronidation was identified by purification from HLC with column chromatographic purification steps. The purified enzyme was identified as α/β hydrolase domain containing 10 (ABHD10) by amino acid sequence analysis. Recombinant ABHD10 expressed in Sf9 cells efficiently deglucuronidated AcMPAG with a K(m) value of 100.7 ± 10.2 μM, which was similar to those in HLM, HLC, and human liver homogenates (HLH). Immunoblot analysis revealed ABHD10 protein expression in both HLC and HLM. The AcMPAG deglucuronidation by recombinant ABHD10, HLC, and HLH were potently inhibited by AgNO(3), CdCl(2), CuCl(2), PMSF, bis-p-nitrophenylphosphate, and DTNB. The CL(int) value of AcMPAG formation from MPA, which was catalyzed by human UGT2B7, in HLH was increased by 1.8-fold in the presence of PMSF. Thus, human ABHD10 would affect the formation of AcMPAG, the immunotoxic metabolite.

摘要

霉酚酸(MPA)是免疫抑制剂霉酚酸酯(MMF)的活性代谢物,主要通过葡萄糖醛酸化代谢为酚基葡萄糖醛酸(MPAG)和酰基葡萄糖醛酸(AcMPAG)。已知可能具有免疫毒性的 AcMPAG 在人肝中发生去葡萄糖醛酸化。然而,据报道,重组β-葡萄糖醛酸酶不能催化该反应。在人肝胞质(HLC)和微粒体(HLM)中均检测到 AcMPAG 的去葡萄糖醛酸化活性。在本研究中,通过用柱色谱纯化步骤从 HLC 中纯化,鉴定出负责 AcMPAG 去葡萄糖醛酸化的酶。通过氨基酸序列分析,鉴定纯化的酶为含 10 个α/β水解酶结构域的蛋白(ABHD10)。在 Sf9 细胞中表达的重组 ABHD10 有效地使 AcMPAG 去葡萄糖醛酸化,K(m)值为 100.7±10.2 μM,与 HLM、HLC 和人肝匀浆(HLH)中的 K(m)值相似。免疫印迹分析显示 ABHD10 蛋白在 HLC 和 HLM 中均有表达。重组 ABHD10、HLC 和 HLH 的 AcMPAG 去葡萄糖醛酸化被 AgNO3、CdCl2、CuCl2、PMSF、双对硝基苯磷酸酯和 DTNB 强烈抑制。在 PMSF 存在的情况下,人 UGT2B7 催化的 MPA 生成 AcMPAG 的 CL(int)值在 HLH 中增加了 1.8 倍。因此,人 ABHD10 可能会影响 AcMPAG 的形成,而 AcMPAG 是一种具有免疫毒性的代谢物。

相似文献

1
Human α/β hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liver.人α/β 水解酶结构域包含 10 (ABHD10)是负责酶去葡糖醛酸化麦考酚酸酰 - 葡糖醛酸在肝脏。
J Biol Chem. 2012 Mar 16;287(12):9240-9. doi: 10.1074/jbc.M111.271288. Epub 2012 Jan 31.
2
An orphan esterase ABHD10 modulates probenecid acyl glucuronidation in human liver.
Drug Metab Dispos. 2014 Dec;42(12):2109-16. doi: 10.1124/dmd.114.059485. Epub 2014 Sep 12.
3
Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.UGT2B7启动子区域和外显子2多态性以及合并用药对体外及成年肾移植患者体内酰基MPAG生成的影响
Pharmacogenet Genomics. 2007 May;17(5):321-30. doi: 10.1097/FPC.0b013e32801430f8.
4
Diabetes mellitus reduces activity of human UDP-glucuronosyltransferase 2B7 in liver and kidney leading to decreased formation of mycophenolic acid acyl-glucuronide metabolite.糖尿病会降低人肝和肾中 UDP-葡萄糖醛酸转移酶 2B7 的活性,导致霉酚酸酰基葡萄糖醛酸代谢物生成减少。
Drug Metab Dispos. 2011 Mar;39(3):448-55. doi: 10.1124/dmd.110.036608. Epub 2010 Dec 1.
5
Identification of protein targets for mycophenolic acid acyl glucuronide in rat liver and colon tissue.大鼠肝脏和结肠组织中霉酚酸酰基葡萄糖醛酸的蛋白质靶点鉴定
Proteomics. 2004 Sep;4(9):2728-38. doi: 10.1002/pmic.200300836.
6
Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes.人肝、肾和小肠微粒体对霉酚酸的葡萄糖醛酸结合和葡萄糖苷结合反应
Br J Pharmacol. 2001 Mar;132(5):1027-34. doi: 10.1038/sj.bjp.0703898.
7
Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.儿科肾移植受者中麦考酚酸具有药理活性的酰基葡萄糖醛酸代谢物的药代动力学及蛋白加合物形成
Ther Drug Monit. 2002 Jun;24(3):390-9. doi: 10.1097/00007691-200206000-00011.
8
Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.参与霉酚酸Ⅱ相代谢的尿苷二磷酸葡萄糖醛酸基转移酶同工型的鉴定。
Drug Metab Dispos. 2005 Jan;33(1):139-46. doi: 10.1124/dmd.104.001651. Epub 2004 Oct 6.
9
Influence of nonsynonymous polymorphisms of UGT1A8 and UGT2B7 metabolizing enzymes on the formation of phenolic and acyl glucuronides of mycophenolic acid.UGT1A8和UGT2B7代谢酶的非同义多态性对霉酚酸酚葡糖醛酸苷和酰基葡糖醛酸苷形成的影响。
Drug Metab Dispos. 2006 Sep;34(9):1539-45. doi: 10.1124/dmd.106.010553. Epub 2006 Jun 21.
10
Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.研究麦考酚酸葡萄糖醛酸代谢物和霉酚酸酯在 Cedia MPA 测定中的交叉反应性。
Ther Drug Monit. 2010 Feb;32(1):79-85. doi: 10.1097/FTD.0b013e3181cc342a.

引用本文的文献

1
The Elk-3 target Abhd10 ameliorates hepatotoxic injury and fibrosis in alcoholic liver disease.Elk-3 靶标 Abhd10 可改善酒精性肝病的肝毒性损伤和纤维化。
Commun Biol. 2023 Jul 3;6(1):682. doi: 10.1038/s42003-023-05055-y.
2
Genomic Insights Into the Population History and Biological Adaptation of Southwestern Chinese Hmong-Mien People.中国西南部苗瑶族群群体历史与生物适应性的基因组学洞察
Front Genet. 2022 Jan 3;12:815160. doi: 10.3389/fgene.2021.815160. eCollection 2021.
3
α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases.α/β-水解酶结构域(ABHD)抑制剂作为治疗与脂质相关疾病的新的潜在治疗选择。
J Med Chem. 2021 Jul 22;64(14):9759-9785. doi: 10.1021/acs.jmedchem.1c00624. Epub 2021 Jul 2.
4
ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5.ABHD10 是一种 S-去棕榈酰酶,通过过氧化物酶 5 影响氧化还原稳态。
Nat Chem Biol. 2019 Dec;15(12):1232-1240. doi: 10.1038/s41589-019-0399-y. Epub 2019 Nov 18.
5
Mitochondrial DNA degradation: A quality control measure for mitochondrial genome maintenance and stress response.线粒体DNA降解:线粒体基因组维持和应激反应的一种质量控制措施。
Enzymes. 2019;45:311-341. doi: 10.1016/bs.enz.2019.08.004.
6
Activity-Based Sensing of -Depalmitoylases: Chemical Technologies and Biological Discovery.基于活性的去棕榈酰酶检测:化学技术与生物发现。
Acc Chem Res. 2019 Nov 19;52(11):3029-3038. doi: 10.1021/acs.accounts.9b00354. Epub 2019 Oct 2.
7
Sequence analysis and structure prediction of ABHD16A and the roles of the ABHD family members in human disease.ABHD16A 的序列分析与结构预测及 ABHD 家族成员在人类疾病中的作用。
Open Biol. 2018 May;8(5). doi: 10.1098/rsob.180017.
8
Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism.哺乳动物α-β水解酶结构域(ABHD)蛋白:细胞信号传导与能量代谢界面处的脂质代谢酶
Biochim Biophys Acta. 2013 Apr;1831(4):792-802. doi: 10.1016/j.bbalip.2013.01.002. Epub 2013 Jan 14.

本文引用的文献

1
In vitro evaluation of inhibitory effects of antidiabetic and antihyperlipidemic drugs on human carboxylesterase activities.体外评估抗糖尿病和抗高血脂药物对人羧酸酯酶活性的抑制作用。
Drug Metab Dispos. 2010 Dec;38(12):2173-8. doi: 10.1124/dmd.110.034454. Epub 2010 Sep 1.
2
Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibiotics.鉴定丙戊酸葡萄糖醛酸苷水解酶为丙戊酸与碳青霉烯类抗生素相互作用的关键酶。
Drug Metab Dispos. 2010 Sep;38(9):1538-44. doi: 10.1124/dmd.110.032938. Epub 2010 Jun 15.
3
Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis.人芳基乙酰胺脱乙酰酶是氟他胺水解的主要酶。
Drug Metab Dispos. 2009 Jul;37(7):1513-20. doi: 10.1124/dmd.109.026567. Epub 2009 Apr 1.
4
Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.羧酸酯酶2基因多态性对日本肾移植受者霉酚酸药代动力学的影响。
Xenobiotica. 2009 May;39(5):407-14. doi: 10.1080/00498250902807338.
5
Different inhibitory effects in rat and human carboxylesterases.大鼠和人羧酸酯酶的不同抑制作用。
Drug Metab Dispos. 2009 May;37(5):956-61. doi: 10.1124/dmd.108.024331. Epub 2009 Feb 18.
6
Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes.人羧酸酯酶1A1、1A2和1A3基因的结构与特性
Pharmacogenet Genomics. 2008 Oct;18(10):911-20. doi: 10.1097/FPC.0b013e32830b0c5e.
7
An unannotated alpha/beta hydrolase superfamily member, ABHD6 differentially expressed among cancer cell lines.ABHD6是一种未注释的α/β水解酶超家族成员,在癌细胞系中差异表达。
Mol Biol Rep. 2009 Apr;36(4):691-6. doi: 10.1007/s11033-008-9230-7. Epub 2008 Mar 22.
8
Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs.参与前药代谢活化的羧酸酯酶同工酶的结构与催化特性。
Molecules. 2008 Feb 18;13(2):412-31. doi: 10.3390/molecules13020412.
9
Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling.双硫仑是一种人类纯化单酰甘油脂肪酶的抑制剂,该酶可调节2-花生四烯酸甘油信号传导。
Chembiochem. 2007 Jul 23;8(11):1293-7. doi: 10.1002/cbic.200700139.
10
Locating proteins in the cell using TargetP, SignalP and related tools.使用TargetP、SignalP及相关工具在细胞中定位蛋白质。
Nat Protoc. 2007;2(4):953-71. doi: 10.1038/nprot.2007.131.